POLITICSglobal
FDA approves higher dose of Wegovy
Single source
Updated 4 hours ago
First seen March 20, 2026 12:50:45Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
The Food and Drug Administration (FDA) on Thursday approved a higher dose of the Wegovy weight loss drug. The manufacturer, Novo Nordisk, increased the semaglutide injection by 4.8 mg to total 7.2 mg. The company says the higher dosage is recommended for those who taken the lower dose already for at least four weeks. Novo Nordisk…